3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Lymphoid
1
Breast
1
Conditions
Breast Neoplasms
3
Prostatic Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Waldenstrom Macroglobulinemia
1
Urogenital Neoplasms
1
Ulnar Neuropathies
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Nurse-Patient Relations
1
Neuroma
1
Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Motor Activity
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
Nivolumab
2
Ipilimumab
2
vedolizumab
1
gallium 68 PSMA-11
1
fludarabine
1
cabozantinib
1
aldesleukin
1
abiraterone
1
abemaciclib
1
Therapeutics
1
Specimen Handling
1
Prednisone
1
Prednisolone
1
Magnetic Resonance Spectroscopy
1
LDP-02
1
Interleukin-2
1
Infliximab
1
Immunoglobulin G
1
Geriatric Assessment
1
Fulvestrant
1
Exercise
1
Disulfides
1
Cyclophosphamide
1
CTLA-4 Antigen
1
CT-P13
1
Biopsy
1
Androgen Antagonists
1
Adrenal Cortex Hormones
1
(225)Ac-PSMA-617
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Urogenital Neoplasms
×
Therapeutics
×
Clear all
NCT05509751
2026-04-28
SOAR
University of Toronto
Phase NA
Active not recruiting
60 enrolled